Annual EPS
-$138.60
+$214.90+60.79%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual earnings per share is -$138.60, with the most recent change of +$214.90 (+60.79%) on December 1, 2023.
- During the last 3 years, NBY annual EPS has risen by +$241.15 (+63.50%).
- NBY annual EPS is now -103.90% below its all-time high of $3553.36, reached on December 31, 2009.
Performance
NBY EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.60
+$0.77+56.20%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly earnings per share is -$0.60, with the most recent change of +$0.77 (+56.20%) on September 1, 2024.
- Over the past year, NBY quarterly EPS has increased by +$12.51 (+95.42%).
- NBY quarterly EPS is now -100.01% below its all-time high of $4499.34, reached on December 31, 2009.
Performance
NBY Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$35.80
+$12.51+25.90%
September 1, 2024
Summary
- As of February 7, 2025, NBY TTM earnings per share is -$35.80, with the most recent change of +$12.51 (+25.90%) on September 1, 2024.
- Over the past year, NBY TTM EPS has increased by +$218.79 (+85.94%).
- NBY TTM EPS is now -101.02% below its all-time high of $3499.60, reached on December 31, 2009.
Performance
NBY TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
NBY EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.8% | +95.4% | +85.9% |
| 3 y3 years | +63.5% | +98.7% | +90.3% |
| 5 y5 years | +75.4% | +98.7% | +90.3% |
NBY EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.8% | at high | +99.6% | at high | +90.4% |
| 5 y | 5-year | at high | +76.4% | at high | +99.7% | at high | +94.5% |
| alltime | all time | -103.9% | +99.4% | -100.0% | +100.0% | -101.0% | +99.9% |
NovaBay Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.60(-56.2%) | -$35.80(-25.9%) |
| Jun 2024 | - | -$1.37(-73.9%) | -$48.31(-47.1%) |
| Mar 2024 | - | -$5.25(-81.6%) | -$91.37(-21.1%) |
| Dec 2023 | -$138.60(-60.8%) | -$28.58(+118.0%) | -$115.87(-54.5%) |
| Sep 2023 | - | -$13.11(-70.5%) | -$254.59(-30.8%) |
| Jun 2023 | - | -$44.43(+49.3%) | -$367.83(-1.5%) |
| Mar 2023 | - | -$29.75(-82.2%) | -$373.45(+7.8%) |
| Dec 2022 | -$353.50(+92.0%) | -$167.30(+32.4%) | -$346.50(+69.8%) |
| Sep 2022 | - | -$126.35(+152.4%) | -$204.05(+46.9%) |
| Jun 2022 | - | -$50.05(+1687.5%) | -$138.95(+0.8%) |
| Mar 2022 | - | -$2.80(-88.7%) | -$137.90(-25.1%) |
| Dec 2021 | -$184.10(-51.5%) | -$24.85(-59.4%) | -$184.10(-6.1%) |
| Sep 2021 | - | -$61.25(+25.0%) | -$196.00(-15.8%) |
| Jun 2021 | - | -$49.00(0.0%) | -$232.75(-36.7%) |
| Mar 2021 | - | -$49.00(+33.3%) | -$367.50(-6.3%) |
| Dec 2020 | -$379.75(-35.4%) | -$36.75(-62.5%) | -$392.00(-22.0%) |
| Sep 2020 | - | -$98.00(-46.7%) | -$502.25(+17.1%) |
| Jun 2020 | - | -$183.75(+150.0%) | -$428.75(+2.9%) |
| Mar 2020 | - | -$73.50(-50.0%) | -$416.50(-35.8%) |
| Dec 2019 | -$588.00(+4.3%) | -$147.00(+500.0%) | -$649.25(+6.0%) |
| Sep 2019 | - | -$24.50(-85.7%) | -$612.50(-15.3%) |
| Jun 2019 | - | -$171.50(-44.0%) | -$722.75(+3.5%) |
| Mar 2019 | - | -$306.25(+177.8%) | -$698.25(+23.9%) |
| Dec 2018 | -$563.50(-4.2%) | -$110.25(-18.2%) | -$563.50(+48.4%) |
| Sep 2018 | - | -$134.75(-8.3%) | -$379.75(-13.9%) |
| Jun 2018 | - | -$147.00(-14.3%) | -$441.00(+2.9%) |
| Mar 2018 | - | -$171.50(-333.3%) | -$428.75(-25.5%) |
| Dec 2017 | -$588.00(-65.7%) | $73.50(-137.5%) | -$575.75(-26.3%) |
| Sep 2017 | - | -$196.00(+45.5%) | -$781.47(-22.0%) |
| Jun 2017 | - | -$134.75(-57.7%) | -$1001.97(-23.4%) |
| Mar 2017 | - | -$318.50(+140.9%) | -$1308.22(-47.9%) |
| Dec 2016 | -$1715.00(-79.5%) | -$132.22(-68.3%) | -$2508.72(-33.5%) |
| Sep 2016 | - | -$416.50(-5.6%) | -$3773.00(-31.7%) |
| Jun 2016 | - | -$441.00(-71.0%) | -$5524.75(-24.7%) |
| Mar 2016 | - | -$1519.00(+8.8%) | -$7337.75(-12.9%) |
| Dec 2015 | -$8354.50(-10.8%) | -$1396.50(-35.6%) | -$8428.00(-12.8%) |
| Sep 2015 | - | -$2168.25(-3.8%) | -$9665.25(-2.8%) |
| Jun 2015 | - | -$2254.00(-13.6%) | -$9947.00(+4.4%) |
| Mar 2015 | - | -$2609.25(-0.9%) | -$9530.50(+1.7%) |
| Dec 2014 | -$9371.25 | -$2633.75(+7.5%) | -$9371.25(-4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | -$2450.00(+33.3%) | -$9812.25(-5.9%) |
| Jun 2014 | - | -$1837.50(-25.0%) | -$10.42 K(-12.8%) |
| Mar 2014 | - | -$2450.00(-20.3%) | -$11.96 K(-7.1%) |
| Dec 2013 | -$12.87 K(+120.8%) | -$3074.75(+0.4%) | -$12.87 K(+9.6%) |
| Sep 2013 | - | -$3062.50(-9.1%) | -$11.75 K(+36.5%) |
| Jun 2013 | - | -$3368.75(0.0%) | -$8605.32(+13.2%) |
| Mar 2013 | - | -$3368.75(+72.7%) | -$7599.63(+9.8%) |
| Dec 2012 | -$5831.54(+7.0%) | -$1950.21(-2467.1%) | -$6920.57(-21.9%) |
| Sep 2012 | - | $82.39(-103.5%) | -$8858.89(+0.4%) |
| Jun 2012 | - | -$2363.06(-12.1%) | -$8826.69(+49.4%) |
| Mar 2012 | - | -$2689.69(-30.8%) | -$5908.80(+1.6%) |
| Dec 2011 | -$5450.16(-3.5%) | -$3888.53(-3493.3%) | -$5817.80(+238.6%) |
| Sep 2011 | - | $114.59(-79.3%) | -$1718.26(-56.9%) |
| Jun 2011 | - | $554.83(-121.4%) | -$3990.54(-34.8%) |
| Mar 2011 | - | -$2598.69(-1331.6%) | -$6119.62(+8.1%) |
| Dec 2010 | -$5646.13(-258.9%) | $211.01(-109.8%) | -$5661.53(+312.3%) |
| Sep 2010 | - | -$2157.69(+37.1%) | -$1373.19(-315.2%) |
| Jun 2010 | - | -$1574.24(-26.5%) | $638.25(-64.7%) |
| Mar 2010 | - | -$2140.60(-147.6%) | $1809.42(-48.3%) |
| Dec 2009 | $3553.36(-130.7%) | $4499.34(-3176.6%) | $3499.60(-209.7%) |
| Sep 2009 | - | -$146.25(-63.7%) | -$3190.89(-38.3%) |
| Jun 2009 | - | -$403.07(-10.5%) | -$5168.76(-37.1%) |
| Mar 2009 | - | -$450.42(-79.4%) | -$8213.47(-29.3%) |
| Dec 2008 | -$11.57 K(+48.8%) | -$2191.16(+3.2%) | -$11.62 K(+1.6%) |
| Sep 2008 | - | -$2124.11(-38.4%) | -$11.43 K(-30.8%) |
| Jun 2008 | - | -$3447.78(-10.5%) | -$16.51 K(-19.0%) |
| Mar 2008 | - | -$3853.24(+91.8%) | -$20.38 K(-1.6%) |
| Dec 2007 | -$7780.98(-68.6%) | -$2008.65(-72.1%) | -$20.71 K(-14.9%) |
| Sep 2007 | - | -$7203.70(-1.5%) | -$24.34 K(+3.2%) |
| Jun 2007 | - | -$7309.86(+74.4%) | -$23.59 K(+1.3%) |
| Mar 2007 | - | -$4192.49(-25.6%) | -$23.29 K(-6.1%) |
| Dec 2006 | -$24.82 K(+52.6%) | -$5638.50(-12.6%) | -$24.82 K(+6.8%) |
| Sep 2006 | - | -$6450.70(-8.0%) | -$23.24 K(+11.4%) |
| Jun 2006 | - | -$7009.39(+22.6%) | -$20.86 K(+16.4%) |
| Mar 2006 | - | -$5718.31(+40.6%) | -$17.92 K(+10.2%) |
| Dec 2005 | -$16.26 K(+23.5%) | -$4065.73(0.0%) | -$16.26 K(+33.3%) |
| Sep 2005 | - | -$4065.73(0.0%) | -$12.20 K(+50.0%) |
| Jun 2005 | - | -$4065.73(0.0%) | -$8131.46(+100.0%) |
| Mar 2005 | - | -$4065.73 | -$4065.73 |
| Dec 2004 | -$13.16 K(+187.0%) | - | - |
| Dec 2003 | -$4586.85 | - | - |
FAQ
- What is NovaBay Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual EPS year-on-year change?
- What is NovaBay Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly EPS year-on-year change?
- What is NovaBay Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals TTM EPS year-on-year change?
What is NovaBay Pharmaceuticals annual earnings per share?
The current annual EPS of NBY is -$138.60
What is the all time high annual EPS for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual earnings per share is $3553.36
What is NovaBay Pharmaceuticals annual EPS year-on-year change?
Over the past year, NBY annual earnings per share has changed by +$214.90 (+60.79%)
What is NovaBay Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of NBY is -$0.60
What is the all time high quarterly EPS for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly earnings per share is $4499.34
What is NovaBay Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, NBY quarterly earnings per share has changed by +$12.51 (+95.42%)
What is NovaBay Pharmaceuticals TTM earnings per share?
The current TTM EPS of NBY is -$35.80
What is the all time high TTM EPS for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high TTM earnings per share is $3499.60
What is NovaBay Pharmaceuticals TTM EPS year-on-year change?
Over the past year, NBY TTM earnings per share has changed by +$218.79 (+85.94%)